The era of simple automation is closing. We are entering the age of Agentic AI, where
autonomous, human-supervised workflows redefine the life sciences workflows and value
chain.
At LabVantage, we view this as a pivotal moment: organizations must orchestrate this shift now or risk digital obsolescence.
Gartner® forecasts that by 2028, more than 70% of the healthcare and lab environment will embrace AI, render traditional pharma commercial models and support obsolete technologies .
To be at the forefront of the change, LSOs must overcome the innovation-compliance divide by:
At LabVantage, we view this as a pivotal moment: organizations must orchestrate this shift now or risk digital obsolescence.
Gartner® forecasts that by 2028, more than 70% of the healthcare and lab environment will embrace AI, render traditional pharma commercial models and support obsolete technologies .
To be at the forefront of the change, LSOs must overcome the innovation-compliance divide by:
- Integrity by Design: Going beyond “black box” AI to machine-readable, auditable clinical justifications that meet the latest GxP requirements.
- Enterprise AI Literacy: Translating AI from a “siloed IT project” to a “core competency” in R&D and commercial operations. The challenge is revolutionary: By 2030, “China’s regulatory body (NMPA) will formalize a scoped agentic AI-powered pathway, reducing drug development timelines by 40% and catalyzing AI review pilot programs globally.”
Download the entire Gartner® report now.
Gartner, Predicts 2026: Agentic AI Reshapes Competitive Advantage in Life Sciences, By Animesh Gandhi, Reuben Harwood, 16 December 2026
